To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian Cancer

Conditions: Epithelial Ovarian Cancer; Stage III Ovarian Cancer; Stage IV Ovarian Cancer Sponsors: The First Hospital of Jilin University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials